187 related articles for article (PubMed ID: 38010006)
1. Oral immunotherapy as a curative treatment for food-allergic preschool children: Current evidence and potential underlying mechanisms.
Barten LJC; Zuurveld M; Faber J; Garssen J; Klok T
Pediatr Allergy Immunol; 2023 Nov; 34(11):e14043. PubMed ID: 38010006
[TBL] [Abstract][Full Text] [Related]
2. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
3. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
4. Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy.
Kim EH; Perry TT; Wood RA; Leung DYM; Berin MC; Burks AW; Cho CB; Jones SM; Scurlock A; Sicherer SH; Henning AK; Dawson P; Lindblad RW; Plaut M; Sampson HA;
J Allergy Clin Immunol; 2020 Oct; 146(4):851-862.e10. PubMed ID: 32535135
[TBL] [Abstract][Full Text] [Related]
5. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
Vickery BP; Berglund JP; Burk CM; Fine JP; Kim EH; Kim JI; Keet CA; Kulis M; Orgel KG; Guo R; Steele PH; Virkud YV; Ye P; Wright BL; Wood RA; Burks AW
J Allergy Clin Immunol; 2017 Jan; 139(1):173-181.e8. PubMed ID: 27522159
[TBL] [Abstract][Full Text] [Related]
6. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling contributes to the establishment of sustained unresponsiveness to food allergens by oral immunotherapy.
Yoneyama T; Nakano N; Hara M; Yamada H; Izawa K; Uchida K; Kaitani A; Ando T; Kitaura J; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T
J Allergy Clin Immunol; 2021 Mar; 147(3):1063-1076.e9. PubMed ID: 32717254
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Food Allergy: Are We There Yet?
Gernez Y; Nowak-Węgrzyn A
J Allergy Clin Immunol Pract; 2017; 5(2):250-272. PubMed ID: 28283151
[TBL] [Abstract][Full Text] [Related]
9. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Oral Immunotherapy Using Low-Egg-Allergen Cookies for Severe Egg-Allergic Children Reduces Allergy Severity and Affects Allergen-Specific Antibodies in Serum.
Maeta A; Matsushima M; Muraki N; Asano M; Takaoka Y; Kameda M; Takahashi K
Int Arch Allergy Immunol; 2018; 175(1-2):70-76. PubMed ID: 29332094
[TBL] [Abstract][Full Text] [Related]
11. Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate.
Mori F; Giovannini M; Barni S; Jiménez-Saiz R; Munblit D; Biagioni B; Liccioli G; Sarti L; Liotti L; Ricci S; Novembre E; Sahiner U; Baldo E; Caimmi D
Front Immunol; 2021; 12():636612. PubMed ID: 34650547
[TBL] [Abstract][Full Text] [Related]
12. Combining anti-IgE with oral immunotherapy.
Lin C; Lee IT; Sampath V; Dinakar C; DeKruyff RH; Schneider LC; Nadeau KC
Pediatr Allergy Immunol; 2017 Nov; 28(7):619-627. PubMed ID: 28782296
[TBL] [Abstract][Full Text] [Related]
13. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
[TBL] [Abstract][Full Text] [Related]
14. Food allergy immunotherapy: Oral immunotherapy and epicutaneous immunotherapy.
Kim EH; Burks AW
Allergy; 2020 Jun; 75(6):1337-1346. PubMed ID: 32034781
[TBL] [Abstract][Full Text] [Related]
15. Oral immunotherapy for the treatment of food allergy.
Ismail IH; Tang ML
Isr Med Assoc J; 2012 Jan; 14(1):63-9. PubMed ID: 22624447
[TBL] [Abstract][Full Text] [Related]
16. Oral immunotherapy for food allergy.
Tang ML
Curr Allergy Asthma Rep; 2009 Jan; 9(1):43-9. PubMed ID: 19063824
[TBL] [Abstract][Full Text] [Related]
17. The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions.
Yee CS; Rachid R
Curr Allergy Asthma Rep; 2016 Apr; 16(4):25. PubMed ID: 26922433
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies in oral allergen-specific immunotherapy: differences among allergens.
Sato S; Yanagida N; Ogura K; Imai T; Utsunomiya T; Iikura K; Goto M; Asaumi T; Okada Y; Koike Y; Syukuya A; Ebisawa M
Int Arch Allergy Immunol; 2014; 164(1):1-9. PubMed ID: 24943470
[TBL] [Abstract][Full Text] [Related]
19. The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults.
Mäntylä J; Thomander T; Hakulinen A; Kukkonen K; Palosuo K; Voutilainen H; Pelkonen A; Kauppi P
Immun Inflamm Dis; 2018 Jun; 6(2):307-311. PubMed ID: 29542268
[TBL] [Abstract][Full Text] [Related]
20. Oral desensitization in IgE-mediated food allergy: Effectiveness and safety.
Calvani M; Bianchi A; Imondi C; Romeo E
Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():49-50. PubMed ID: 32017216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
